Luxury skincare brand Cha Ling has closed all its physical stores in China to optimize its retail strategy as Covid-19 disruptions continue
The LVMH-owned Cha Ling, which operated stores in China for five years, also shut down its WeChat online store.
The brand will continue to sell its products across LVMH’s Sephora China stores as an exclusive brand. It will also retain its Tmall store.
Cha Ling entered China in 2017, a year after it was founded by Laurent Boillot, who is currently CEO of Hennessy.
Since then, the brand has opened three stores in the country: Shanghai HKRI Taikoo Hui, Shanghai IFC, and Hangzhou’s MixC Mall.
The LVMH-owned luxury skincare label is known for blending Eastern and Western cultures through its brand philosophy of "Beauty with a meaning, for you, for the others, and the world."
Cha Ling joins a series of brands closing stores in China, such as L’Oreal-owned beauty brand Maybelline, due to the uncertainty of the Covid-19 situation.


US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Bets
The pandemic is still disrupting young people’s careers
S&P 500, Nasdaq Futures Rise as Iran Risks and CPI Loom
Heritage, desire and diplomacy: why China still values scotch whisky
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Want to cut your energy bills? Here’s how five experts are doing it
JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
ADNOC Gas Targets Up to $4B Profit in 2026
Oil Prices Rise as Hormuz Reopening Remains Uncertain
Shein Scales Back Vietnam Operations as US Trade Rules Shift
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 



